Question the choice of utility values make a real difference? 

How do PD versus PK affect sensitivity of utility to dose?

Ditto for multimodality and RLE.

When does the Pr(T) = 1/3 rule from Phase 1 3+3 designs come close to the optimal E(U), and when is it way off?
 for a DUE paper

When does the choice of utility values make a real difference?

How do PD versus PK affect sensitivity of utility to dose?

Ditto for multimodality and RLE.

When does the Pr(T) = 1/3 rule from Phase 1 3+3 designs come close to the optimal E(U), and when is it way off?

